PREMJI INVEST
P
urposE
P
hilosophy
P
artnerships
P
eople
P
erspectives
US
US
India
Back to full portfolio
Market-leading antibody drug discovery platform.
WEBSITE
Founder(s)
Tillman Gerngross
THEME(S)
No items found.
SECTOR(S)
Healthcare
Investment Stage
Growth
Company Status
Private
Perspectives
More about Adimab
Perspectives
2023 Update on Clinical Pipeline
January 9, 2024
Adimab
2023 Update on Clinical Pipeline
Perspectives
Provides Year-End Update on 2023 Partnership Activities
January 8, 2024
Adimab
Provides Year-End Update on 2023 Partnership Activities
